VEGFA and neoplasm: TAVO412 only suppressed tumor-derived human VEGF-A, but not the host-derived mouse VEGF-A, which was secreted from mouse fibroblast and immune cells that surrounded the tumor mass supporting residual angiogenesis and growth (59, 60).